OXURION to Participate in the 10th edition of Degroof Petercam’s Healthcare Conference
OXURION to Participate in the 10th edition of Degroof Petercam’s Healthcare Conference
January 18, 2022
PDF Version 381.8 KB
Leuven, BELGIUM, Boston, MA, US – January 18, 2022 – 08.00 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will participate in the 10th edition of Degroof Petercam's Healthcare Conference:
10th edition of Degroof Petercam's Healthcare Conference
January 24-28, 2022
1x1 and small group investor meetings only
For more information, please visit Oxurion's events page.